Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FBD Holding Plc Board/Management Information 2019

Aug 19, 2019

1964_rns_2019-08-19_f7076b0f-d26c-43d2-a952-2cf4203a92b8.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5360J

FBD Holdings PLC

19 August 2019

FBD Holdings plc

19 August 2019

Changes to Board Committee Chairs and Appointment of Senior Independent Director

FBD Holdings plc is pleased to announce the following changes with immediate effect.

Ms Mary Brennan, independent non-executive Director, has been appointed as Chair of the Audit Committee.

Mr David O'Connor, independent non-executive Director, has been appointed as Chair of the Remuneration Committee.

Mr David O'Connor has been appointed Senior Independent Director.

Ends

For Reference

Telephone

FBD Holdings plc

Derek Hall, Company Secretary

+353 1 409 3469   

About FBD Holdings plc

FBD is one of Ireland's largest property and casualty insurers looking after the insurance needs of farmers, private individuals and business owners.

The following details relate to FBD's ordinary shares of €0.60 each which are publicly traded:

Listing Irish Stock Exchange UK Listing Authority
Listing Category Premium Premium (Equity)
Trading Venue Irish Stock Exchange London Stock Exchange
Market Main Securities Market Main Market
ISIN IE0003290289 IE0003290289
Ticker FBD.I or EG7.IR FBH.L
FBD Holdings plc, FBD House, Bluebell, Dublin 12, Ireland
Registered in Dublin, Ireland.   Registered Number 135882

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOASFAFLUFUSEDA